Persistence of Drug-Resistant Leukemic Stem Cells and Impaired NK Cell Immunity in CML Patients Depend on MIR300 Antiproliferative and PP2A-Activating Functions
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 19, 2020
- Source ID
- 10.1158/2643-3249.bcd-19-0039
Entities
People
- Alistair G. Reid
- Ann-kathrin Eisfeld
- Bin Zhang
- Bruno Calabretta
- Carlo Gambacorti-passerini
- Catriona H. M. Jamieson
- Christopher Harman
- Christopher J. Walker
- Danilo Perrotti
- Denis-claude Roy
- Dragana Milojkovic
- Fabio Stagno
- Francesco Dazzi
- Gabriel Pineda
- Garrett Fitzgerald
- Georgios Nteliopoulos
- Giovannino Silvestri
- Guido Marcucci
- Jane F. Apperley
- Jason G. Harb
- Jianfei Qi
- Justin J. Ellis
- Katerina Machova Polakova
- Klara Srutova
- Lorenzo Stramucci
- Maria R. Baer
- Martin Guimond
- Michael W. Deininger
- Moutuaata M. Moutuou
- Paolo Neviani
- Paolo Vigneri
- Peter Hokland
- Philippa C. May
- Ramiro Garzon
- Rossana Trotta
- Shuzhen Wang
- Xiaoxuan Fan
- Ying Zou
Organizations
- American Cryonics Society
- Cancer Research Society
- National Institutes of Health
- National Natural Science Foundation of China
- United States Department of Defense